LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04328077. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2a Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Orally Administered TERN-101 Tablets in Adult Patients With Presumed Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetics (PK) of TERN-101 in non-cirrhotic NASH patients.
Study identification
- NCT ID
- NCT04328077
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2020 (Actual)
- Primary completion
- May 19, 2021 (Actual)
- Completion
- May 19, 2021 (Actual)
- Last update posted
- Aug 9, 2022
2020 – 2021
United States locations
- U.S. sites
- 31
- U.S. states
- 12
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Terns Clinical Study Site 1017 | Chandler | Arizona | 85224 | — |
| Terns Clinical Study Site 1018 | Tucson | Arizona | 85712 | — |
| Terns Clinical Study Site 1024 | Tucson | Arizona | 85712 | — |
| Terns Clinical Study Site 1004 | Coronado | California | 92117 | — |
| Terns Clinical Study Site 1035 | Fresno | California | 93720 | — |
| Terns Clinical Study Site 1013 | La Jolla | California | 92037 | — |
| Terns Clinical Study Site 1016 | Los Angeles | California | 90036 | — |
| Terns Clinical Study Site 1008 | Montclair | California | 91763 | — |
| Terns Clinical Study Site 1001 | Panorama City | California | 91402 | — |
| Terns Clinical Study Site 1012 | Gainesville | Florida | 32610 | — |
| Terns Clinical Study Site 1007 | Hialeah | Florida | 33013 | — |
| Terns Clinical Study Site 1028 | Hialeah | Florida | 33014 | — |
| Terns Clinical Study Site 1009 | Miami | Florida | 33166 | — |
| Terns Clinical Study Site 1033 | Orlando | Florida | 32806 | — |
| Terns Clinical Study Site 1032 | Indianapolis | Indiana | 46202 | — |
| Terns Clinical Study Site 1010 | Bastrop | Louisiana | 71220 | — |
| Terns Clinical Study Site 1037 | New Orleans | Louisiana | 70121 | — |
| Terns Clinical Study Site 1023 | Shreveport | Louisiana | 71105 | — |
| Terns Clinical Study Site 1002 | Baltimore | Maryland | 21202 | — |
| Terns Clinical Study Site 1011 | Boston | Massachusetts | 02118 | — |
| Terns Clinical Study Site 1038 | Florham Park | New Jersey | 07932 | — |
| Terns Clinical Study Site 1027 | Durham | North Carolina | 27710 | — |
| Terns Clinical Study Site 1014 | Hermitage | Tennessee | 37076 | — |
| Terns Clinical Study Site 1005 | Arlington | Texas | 76012 | — |
| Terns Clinical Study Site 1025 | Georgetown | Texas | 78628 | — |
| Terns Clinical Study Site 1021 | Houston | Texas | 77030 | — |
| Terns Clinical Study Site 1029 | Houston | Texas | 77030 | — |
| Terns Clinical Study Site 1006 | San Antonio | Texas | 78215 | — |
| Terns Clinical Study Site 1003 | San Antonio | Texas | 78229 | — |
| Terns Clinical Study Site 1019 | San Antonio | Texas | 78229 | — |
| Terns Clinical Study Site 1022 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04328077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2022 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.